ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 608

Prevalence of Radiographic Entheseal Lesions at the Hip and Pelvic Region in Patients with Ankylosing Spondylitis versus Controls

Freke Wink1, Thomas Diemel 2, Suzanne Arends 2 and Anneke Spoorenberg 2, 1Medical Center Leeuwarden, Leeuwarden, Netherlands, 2University Medical Center Groningen, Groningen, Netherlands

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Ankylosing spondylitis (AS), axial spondyloarthritis, enthesis and radiography

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Enthesitis is one of the features of ankylosing spondylitis (AS). High prevalence of structural and inflammatory ultrasound lesions of peripheral entheses are found in AS patients. Furthermore, plain radiographs provide good imaging of peripheral enthesopathy at well-defined skeletal sites1. There are several entheseal sites at the pelvis and hip region, but little is known about the presence of structural entheseal anomalies at these sites in AS. Our aim was to investigate the prevalence of radiographic entheseal lesions at the hip and pelvic region in patients with AS compared to control subjects.

Methods: The present analysis was performed in 214 patients from the Groningen Leeuwarden Axial SpA (GLAS) cohort study and 100 control subjects. The AS patients were included between November 2004 and December 2010 and had available anteroposterior (AP) pelvis radiographs at baseline. All patients fulfilled the modified New York criteria for AS. AP pelvis radiographs from control subjects matched for age and gender were obtained from the radiology department of the University Medical Center Groningen (UMCG).

Radiographs with blinded sacroiliac joints were randomized and scored by two trained readers. Anomalies with absolute agreement were reported. The entheseal sites scored were: trochanter major, trochanter minor, os ischium, crista iliaca, both left and right side and symphysis pubis. The following 3 anomalies were scored: cortical irregularities/erosions, calcifications and enthesophytes.

Results: Of the 214 AS patients, 148 (69%) were male, mean age was 42.5 ± 11.6 years, 171 (80%) were HLA-B27 positive and median symptom duration was 16 years (IQR 8-24). Patients had active disease with BASDAI 5.6 ± 1.9 and ASDAScrp 3.5 ± 0.9. Reader agreement on the entheseal lesions was overall moderate with Cohen’s kappa between 0.42 and 0.78.

Radiographic entheseal lesions at the hip and pelvic region were found in 160 (75%) patients and 58 (58%) controls. In total, 602 lesions were found of which 478 (80%) were present in AS patients. For both groups, the most prevalent lesion was irregularity/erosion (n=333 in 150 (70%) AS patients and n=85 in 50 (50%) controls), followed by enthesophytes (n=129 in 64 (30%) AS patients and n=37 in 21 (21%) controls). In both AS patients and controls, most lesions were found at the os ischii (n=275 in 138 (65%) AS patients and n=97 in 53 (53%) controls).

Conclusion: Radiographic entheseal lesions at the hip and pelvic region are more prevalent in AS patients compared to controls. Irregularities and erosions were most frequently found in both groups, especially at the os ischium. These new findings concerning structural entheseal lesions at the pelvis and hip region contributes to the knowledge of entheseal involvement in AS.


Disclosure: F. Wink, Abbvie, 2, 5, Pfizer, 2, 5, UCB, 2; T. Diemel, None; S. Arends, Pfizer, 2; A. Spoorenberg, Pfizer, 2, 5, Abbvie, 2, 5, UCB, 2.

To cite this abstract in AMA style:

Wink F, Diemel T, Arends S, Spoorenberg A. Prevalence of Radiographic Entheseal Lesions at the Hip and Pelvic Region in Patients with Ankylosing Spondylitis versus Controls [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-radiographic-entheseal-lesions-at-the-hip-and-pelvic-region-in-patients-with-ankylosing-spondylitis-versus-controls/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-radiographic-entheseal-lesions-at-the-hip-and-pelvic-region-in-patients-with-ankylosing-spondylitis-versus-controls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology